Haidong Ma

Key Laboratory Of Biotherapy And Regenerative Medicine
Lanzhou, 730000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations.

CBC3T-3: a novel patient-derived cisplatin-resistant distal cholangiocarcinoma cell line harboring multiple TP53 missense mutations.

Journal: Human cell

Published: November 06, 2025

Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity.

Targeting cancer-associated fibroblast-activated HGF/c-MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity.

Journal: Acta pharmaceutica Sinica. B

Published: April 10, 2025

Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6.

Biological and genetic characterization of a newly established human primary multidrug-resistant distal cholangiocarcinoma cell line, CBC3T-6.

Journal: Scientific reports

Published: June 27, 2024

Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia.

Design of the distribution of iron oxide (Fe3O4) nano-particle drug in realistic cholangiocarcinoma model and the simulation of temperature increase during magnetic induction hyperthermia.

Journal: Pharmacological research

Published: May 31, 2024

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.

Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications.

Journal: Medical review (2021)

Published: March 27, 2024

Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing.

Beyond ribosomal function: RPS6 deficiency suppresses cholangiocarcinoma cell growth by disrupting alternative splicing.

Journal: Acta pharmaceutica Sinica. B

Published: February 20, 2024

Regular use of paracetamol and risk of liver cancer: a prospective cohort study.

Regular use of paracetamol and risk of liver cancer: a prospective cohort study.

Journal: BMC cancer

Published: October 05, 2023

Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.

Establishment and characterization of a novel hilar cholangiocarcinoma cell line, CBC3T-1.

Journal: Human cell

Published: September 11, 2023

Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer.

Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer.

Journal: Frontiers in oncology

Published: August 25, 2023

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota.

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota.

Journal: Frontiers in pharmacology

Published: May 05, 2023

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease.

Journal: Frontiers in surgery

Published: November 21, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026